세계의 겸상 적혈구증 치료 시장(2025-2029년)

The sickle cell disease treatment market is forecasted to grow by USD 3,345.1 mn during 2024-2029, accelerating at a CAGR of 16.2% during the forecast period. The report on the sickle cell disease treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of sickle cell disease, government and nonprofit support, and improved healthcare infrastructure in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's sickle cell disease treatment market is segmented as below:

By Therapeutic Area

• Blood transfusion
• Pharmacotherapy
• Bone marrow transplant

By End-user

• Hospitals
• Specialty clinics
• Ambulatory surgical centers

By Indication

• Sickle cell anemia
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the shift from symptom management to curative approaches as one of the prime reasons driving the sickle cell disease treatment market growth during the next few years. Also, strategic partnerships and collaborations and focus on awareness campaigns will lead to sizable demand in the market.

The report on the sickle cell disease treatment market covers the following areas:

• Sickle Cell Disease Treatment Market sizing
• Sickle Cell Disease Treatment Market forecast
• Sickle Cell Disease Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sickle cell disease treatment market vendors that include AbbVie Inc., Agios Inc., AstraZeneca Plc, bluebird bio Inc., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, CRISPR Therapeutics AG, Editas Medicine Inc., Emmaus Medical Inc., F. Hoffmann La Roche Ltd., Intellia Therapeutics Inc., Medunik USA, Novartis AG, Pfizer Inc., Prolong Pharmaceuticals LLC, Sanofi SA, and Vertex Pharmaceuticals Inc.. Also, the sickle cell disease treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Therapeutic Area
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Sickle Cell Disease Treatment Market 2019 - 2023
  • Historic Market Size - Data Table on Global Sickle Cell Disease Treatment Market 2019 - 2023 ($ million)
• 5.2 Therapeutic Area segment analysis 2019 - 2023
  • Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.4 Indication segment analysis 2019 - 2023
  • Historic Market Size - Indication Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact Analysis of U.S. Tariffs on Global Sickle Cell Disease Treatment Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Therapeutic Area

• 8.1 Market segments
  • Chart on Therapeutic Area - Market share 2024-2029 (%)
  • Data Table on Therapeutic Area - Market share 2024-2029 (%)
• 8.2 Comparison by Therapeutic Area
  • Chart on Comparison by Therapeutic Area
  • Data Table on Comparison by Therapeutic Area
• 8.3 Blood transfusion - Market size and forecast 2024-2029
  • Chart on Blood transfusion - Market size and forecast 2024-2029 ($ million)
  • Data Table on Blood transfusion - Market size and forecast 2024-2029 ($ million)
  • Chart on Blood transfusion - Year-over-year growth 2024-2029 (%)
  • Data Table on Blood transfusion - Year-over-year growth 2024-2029 (%)
• 8.4 Pharmacotherapy - Market size and forecast 2024-2029
  • Chart on Pharmacotherapy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Pharmacotherapy - Market size and forecast 2024-2029 ($ million)
  • Chart on Pharmacotherapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Pharmacotherapy - Year-over-year growth 2024-2029 (%)
• 8.5 Bone marrow transplant - Market size and forecast 2024-2029
  • Chart on Bone marrow transplant - Market size and forecast 2024-2029 ($ million)
  • Data Table on Bone marrow transplant - Market size and forecast 2024-2029 ($ million)
  • Chart on Bone marrow transplant - Year-over-year growth 2024-2029 (%)
  • Data Table on Bone marrow transplant - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by Therapeutic Area
  • Market opportunity by Therapeutic Area ($ million)
  • Data Table on Market opportunity by Therapeutic Area ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2024-2029
  • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
• 9.4 Specialty clinics - Market size and forecast 2024-2029
  • Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
• 9.5 Ambulatory surgical centers - Market size and forecast 2024-2029
  • Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
  • Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
  • Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Indication

• 10.1 Market segments
  • Chart on Indication - Market share 2024-2029 (%)
  • Data Table on Indication - Market share 2024-2029 (%)
• 10.2 Comparison by Indication
  • Chart on Comparison by Indication
  • Data Table on Comparison by Indication
• 10.3 Sickle cell anemia - Market size and forecast 2024-2029
  • Chart on Sickle cell anemia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Sickle cell anemia - Market size and forecast 2024-2029 ($ million)
  • Chart on Sickle cell anemia - Year-over-year growth 2024-2029 (%)
  • Data Table on Sickle cell anemia - Year-over-year growth 2024-2029 (%)
• 10.4 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 10.5 Market opportunity by Indication
  • Market opportunity by Indication ($ million)
  • Data Table on Market opportunity by Indication ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.10 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.12 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.14 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.15 Brazil - Market size and forecast 2024-2029
  • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
• 12.16 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 15.5 Agios Inc.
  • Agios Inc. - Overview
  • Agios Inc. - Product / Service
  • Agios Inc. - Key offerings
  • SWOT
• 15.6 bluebird bio Inc.
  • bluebird bio Inc. - Overview
  • bluebird bio Inc. - Product / Service
  • bluebird bio Inc. - Key offerings
  • SWOT
• 15.7 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
  • SWOT
• 15.8 CHIESI Farmaceutici SpA
  • CHIESI Farmaceutici SpA - Overview
  • CHIESI Farmaceutici SpA - Product / Service
  • CHIESI Farmaceutici SpA - Key offerings
  • SWOT
• 15.9 CRISPR Therapeutics AG
  • CRISPR Therapeutics AG - Overview
  • CRISPR Therapeutics AG - Product / Service
  • CRISPR Therapeutics AG - Key offerings
  • SWOT
• 15.10 Editas Medicine Inc.
  • Editas Medicine Inc. - Overview
  • Editas Medicine Inc. - Product / Service
  • Editas Medicine Inc. - Key offerings
  • SWOT
• 15.11 Emmaus Medical Inc.
  • Emmaus Medical Inc. - Overview
  • Emmaus Medical Inc. - Product / Service
  • Emmaus Medical Inc. - Key offerings
  • SWOT
• 15.12 Intellia Therapeutics Inc.
  • Intellia Therapeutics Inc. - Overview
  • Intellia Therapeutics Inc. - Product / Service
  • Intellia Therapeutics Inc. - Key offerings
  • SWOT
• 15.13 Medunik USA
  • Medunik USA - Overview
  • Medunik USA - Product / Service
  • Medunik USA - Key offerings
  • SWOT
• 15.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.16 Prolong Pharmaceuticals LLC
  • Prolong Pharmaceuticals LLC - Overview
  • Prolong Pharmaceuticals LLC - Product / Service
  • Prolong Pharmaceuticals LLC - Key offerings
  • SWOT
• 15.17 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 15.18 Vertex Pharmaceuticals Inc.
  • Vertex Pharmaceuticals Inc. - Overview
  • Vertex Pharmaceuticals Inc. - Product / Service
  • Vertex Pharmaceuticals Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations